Clinical Pharmacy Services Publications

 

Clinical Pharmacy Services, a unit of the Commonwealth Medicine division at the University of Massachusetts Medical School, provides customized, results-oriented prescription drug management services for government, nonprofit, and commercial clients. Staff members participate in a range of activities and initiatives to contribute to the advancement of the pharmacy profession through scholarship. This collection showcases publications and presentations written by Clinical Pharmacy Services staff.

Follow


Publications from 2018

PDF

A Comparison of the Costs Associated with the Administration of Select High-cost Infused Medications in Three Sites of Care for a State Medicaid Population, Sage Bagwell, Pavel Lavitas, Thomas C. Pomfret, Bonnie C. Greenwood, Nicole M. Trask, Stephanie Tran, Nancy L. Schiff, Tasmina Hydery, Patricia Leto, Mylissa K. Price, Caroline J. Alper, Kimberly J. Lenz, and Paul L. Jeffrey

Link

An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid Patients, Ashley N. Chiara, Neha Kashalikar, Thomas C. Pomfret, Kimberly J. Lenz, Donna M. Faber, Joel Goldstein, Karen M. Clements, Michael Angelini, Patricia Leto, and Paul L. Jeffrey

PDF

A view of the drug pricing blueprint, Bonnie C. Greenwood

Link

Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1 Infection: A Retrospective Cohort Study in a Medicaid Population, George Kouris, Tasmina Hydery, Bonnie C. Greenwood, Pavel Lavitas, Mylissa K. Price, Karen M. Clements, Caroline J. Alper, Kimberly J. Lenz, and Paul L. Jeffrey

PDF

Impact of a Pilot Outreach Program upon Provider Awareness and Prescribing of a Concerning Opioid Combination Regimen, Briana Santaniello, Thomas C. Pomfret, Mark A. Tesell, Nicole M. Trask, Caroline J. Alper, Karen M. Clements, Vincent Palumbo, Kimberly Lenz, and Paul L. Jeffrey

PDF

Impact of Lumacaftor/Ivacaftor on Pulmonary Exacerbation Rates in Members with Cystic Fibrosis in a Medicaid Population, Mark A. Tesell, Karen Stevens, Bonnie C. Greenwood, Caroline J. Alper, Kimberly J. Lenz, and Paul L. Jeffrey

PDF

A Budget Impact Model for Two Investigational Agents for the Treatment of Nonalcoholic Steatohepatitis, Nicole M. Trask, Pavel Lavitas, and Vincent Palumbo

Publications from 2017

PDF

Evaluation of the impact of a prescribing guideline on the use of intraoperative dexmedetomidine at a tertiary academic medical center, Abdullah M. Alhammad, Nour A. Baghdady, Rachel A. Mullin, and Bonnie C. Greenwood

PDF

Health Plan Member Outreach and Engagement: Best Practices, Jeff A. Auger

PDF

Evaluating the Impact of Interventions by a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup on Medication Prescribing Trends in a Medicaid Population, Ashley N. Camilo, Neha Kashalikar, Thomas C. Pomfret, Donna M. Faber, Kimberly J. Lenz, Joel Goldstein, Karen M. Clements, Michael Angelini, Patricia Leto, and Paul L. Jeffrey

Link

Increasing Your Star Power with a Successful MTM Program, Bonnie C. Greenwood

Link

Evaluation of Progesterone Utilization and Birth Outcomes in a State Medicaid Plan, Tasmina Hydery, Mylissa K. Price, Bonnie C. Greenwood, Mito Takeshita, Parag S. Kunte, Rose P. Mauro, Kimberly J. Lenz, and Paul L. Jeffrey

PDF

Evaluation of Progesterone Agent Utilization and Birth Outcomes in a State Medicaid Plan, Tasmina Hydery, Mylissa K. Price, Bonnie C. Greenwood, Mito Takeshita, Rose Mauro, Parag Kunte, Kimberly J. Lenz, and Paul L. Jeffrey

PDF

Effectiveness of Ledipasvir/Sofosbuvir and Predictors of Treatment Failure in Members with Hepatitis C Genotype 1: A Retrospective Cohort Study in a Medicaid Population, George Kouris, Tasmina Hydery, Bonnie C. Greenwood, Pavel Lavitas, Caroline J. Alper, Mylissa K. Price, Karen M. Clements, Kimberly J. Lenz, and Paul L. Jeffrey

Link

Substance Use Disorder Privacy Law Limits Both Payers, Prescribers, Kimberly J. Lenz and Tyson Thompson

Link

The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population, Stephanie Tran, Pavel Lavitas, Karen Stevens, Bonnie C. Greenwood, Karen M. Clements, Caroline J. Alper, Kimberly J. Lenz, Mylissa K. Price, Tasmina Hydery, Jennifer L. Arnold, Mito Takeshita, Rachel Bacon, Justin P. Peristere, and Paul L. Jeffrey

PDF

Pipeline Trends - December 2017, Nicole M. Trask and Sage Bagwell

Publications from 2016

Link

AMCP Partnership Forum: Navigating Innovations in Diabetes Care, Academy of Managed Care Pharmacy and Mark A. Tesell

Link

Access to New Medications for Hepatitis C for Medicaid Members: A Retrospective Cohort Study, Karen M. Clements, Robin E. Clark, Pavel Lavitas, Parag Kunte, Camilla S. Graham, Elizabeth O'Connell, Kimberly J. Lenz, and Paul Jeffrey

PDF

Pipeline Trends April 2016, Timothy Cummins

PDF

Pipeline Trends December 2016, Timothy Cummins

PDF

The Pediatric Behavioral Health Medication Initiative, Neha Kashalikar

Link

Overview of Comprehensive Hepatitis C Virus Medication Management in a State Medicaid Program, Pavel Lavitas, Mark A. Tesell, Tasmina Hydery, Bonnie C. Greenwood, Mylissa K. Price, Kimberly J. Lenz, and Paul L. Jeffrey

PDF

Planning for the 2017 Specialty Drug Spend: When Costs are Steep but Pockets are Not Deep, Nicole M. Trask

Publications from 2015

PDF

Risk and Benefit of the Concomitant Use of Benzodiazepines and Opiates, Michael Angelini

PDF

Implementation of a Pediatric Behavioral Health Medication Safety Initiative in a State Medicaid Program, Donna M. Faber, Michael Angelini, Payal N. Kotadiya, Kimberly J. Lenz, Amy L. Levy, and Paul L. Jeffrey

PDF

Motivational Interviewing from Theory to Practice: Engaging the Patient Throughout the MTM Encounter, Payal N. Kotadiya

PDF

One State's Perspective on the Management of Hepatitis C Drugs, Pavel Lavitas

Publications from 2014

PDF

Overview of a Hepatitis C Medication Monitoring Program in a State Medicaid Program, Pavel Lavitas, Kimberly J. Lenz, Tasmina Hydery, Mark Tesell, J. Gagnon, and Paul L. Jeffrey

Publications from 2012

PDF

Pipeline Trends 2012, Timothy Cummins

PDF

The Pharmacist: An Integral Component of the Care Coordination Team for High-Cost, Medically Complex Populations, Timothy Cummins

PDF

Drug Utilization and the Pharmaceutical Pipeline: Correctional Health Care Formulary Considerations, Erik Hamel

Publications from 2011

PDF

Personalized Medication Management: A Medicaid Community Service Model, Jessica Carpenter and Karen Coderre

PDF

Pipeline Predictor Rx, Timothy Cummins

PDF

Pipeline Trends 2011, Timothy Cummins

PDF

The Clinical Pharmacy Services Insider 2011, Timothy Cummins

Publications from 2009

Link

Panitumumab-Related Hypomagnesemia in Patients With Colorectal Cancer, Haiying Cheng, David C. Gammon, Traci M. Dutton, and Bilal Piperdi

Link

Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis, David C. Gammon, Traci M. Dutton, Bilal Piperdi, Jason Zybert, Steven H. Wolfe, Erin Nguyen, Dalia Sbat, Venu G. Pillarisetty, Mary E. Sullivan, and Giles F. Whalen

Publications from 2008

Link

Managing reduced methotrexate clearance in a patient with a heterozygous methylenetetrahydrofolate reductase gene polymorphism, David C. Gammon, Mansi S. Bhatt, Bhavini Patel, Meghan Anderson, Alixis Van Horn, and Michael J. Glantz

Link

A successful veno-occlusive disease (VOD) prophylaxis strategy for patients undergoing stem cell transplantation, David C. Gammon, Kristi Holt, Traci M. Dutton, Janet Rogers, and Samer Al-Homsi

Link

Intraurethral fluorouracil and lidocaine for intraurethral condyloma acuminata, David C. Gammon, Keith A. Reed, Mausaum Patel, and Kethandapatti Balaji

Publications from 2006

Link

Intrathecal topotecan in adult patients with neoplastic meningitis, David C. Gammon, Mansi S. Bhatt, Lan Tran, Alexis Van Horn, Matthew Benvenuti, and Michael J. Glantz

Link

Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy, Donald A. Hutcherson, David C. Gammon, Mansi S. Bhatt, and Melissa Faneuf

Publications from 2004

Link

Safety and cost-effectiveness of paclitaxel administered as a 1-hour infusion versus a 3-hour infusion for various malignancies, David C. Gammon and Margaret W. Lizotte

Link

Superselective Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Experience with a New Emulsion., David C. Gammon, Sekhar Rao, Ducksoo Kim, Pankaj Bhargava, and Timothy R. Bartlett

Publications from 2003

Link

Hypersensitivity and idiosyncratic reactions to oxaliplatin, Pankaj Bhargava, David C. Gammon, and Michael J. McCormick

Link

Zoledronic Acid vs Pamidronate for the Prevention of Hypercalcemia of Malignancy or Bone Metastases in Hospital Outpatients: Time Analysis and Economic Implications., David C. Gammon and Hoang T. Le